Actualities in Procedural Sedation: Remimazolam

Clinical trial NCT07362173 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07362173
Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

ASA Class III/IV Patients COPD III/IV Age 65 and Older Multiple Organ Failure

Start date: 2025-03-01
Primary completion: 2026-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.